|
Volumn 7, Issue 44, 2015, Pages 18542-18551
|
Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL DEATH;
CONTROLLED DRUG DELIVERY;
INDIUM;
NANOPARTICLES;
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;
TARGETED DRUG DELIVERY;
THERANOSTICS;
TUMORS;
ANTICANCER ACTIVITIES;
CANCER THERAPY;
DELIVERY SYSTEMS;
DOSE-DEPENDENT;
G2/M CELL CYCLE ARREST;
PARENT COMPOUNDS;
PARENTERAL ADMINISTRATION;
SPECT IMAGING;
DISEASES;
DRUG CARRIER;
ETOPOFOS;
ETOPOSIDE;
INDIUM;
NANOPARTICLE;
ORGANOPHOSPHORUS COMPOUND;
ANALOGS AND DERIVATIVES;
ANIMAL;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMISTRY;
DRUG EFFECTS;
DRUG SCREENING;
G2 PHASE CELL CYCLE CHECKPOINT;
HUMAN;
LUNG NEOPLASMS;
M PHASE CELL CYCLE CHECKPOINT;
METABOLISM;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
PROCEDURES;
THERANOSTIC NANOMEDICINE;
ANIMALS;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG CARRIERS;
ETOPOSIDE;
G2 PHASE CELL CYCLE CHECKPOINTS;
HUMANS;
INDIUM;
LUNG NEOPLASMS;
M PHASE CELL CYCLE CHECKPOINTS;
MICE;
MICE, NUDE;
NANOPARTICLES;
ORGANOPHOSPHORUS COMPOUNDS;
THERANOSTIC NANOMEDICINE;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 84946866815
PISSN: 20403364
EISSN: 20403372
Source Type: Journal
DOI: 10.1039/c5nr04509f Document Type: Article |
Times cited : (17)
|
References (29)
|